Diabetes Medication
- All
- News
- Videos
- Web Stories
-
The 25 Most Googled Health Questions In India This Year, And Their Answers
- Monday December 8, 2025
- Health | Written by Debosmita Ghosh
Top Health Googled Questions: Indians googled several queries related to issues like blood pressure, cholesterol, diabetes, kidney stones and more. Check here the most Googled health questions in India and their answers.
-
www.ndtv.com
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
- Tuesday December 2, 2025
- Health | NDTV
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
www.ndtv.com
-
US Adds New Grounds To Deny Visas: Obesity, Diabetes, Heart Disease
- Friday November 7, 2025
- World News | Edited by Anushree Jonko
Foreign nationals applying for a visa to live in the US might be rejected if they have health conditions such as diabetes or obesity, according to a government directive issued by the Trump administration on Thursday.
-
www.ndtv.com
-
IIT Madras Patents Affordable, Painless Glucose Monitor For Diabetics
- Thursday November 6, 2025
- India News | Press Trust of India
Researchers at the Indian Institute of Technology Madras have patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients, officials said on Wednesday.
-
www.ndtv.com
-
Obesity: Why New Medications Are Not Miracle Cures
- Friday November 7, 2025
- Health | The Conversation
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
www.ndtv.com
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
- Thursday October 30, 2025
- Health | Written by NDTV Health Desk
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
www.ndtv.com
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
- Wednesday October 8, 2025
- Health | Edited by NDTV News Desk
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
How PCOS-Linked Insulin Resistance Increases Type-2 Diabetes Risk
- Tuesday September 9, 2025
- Health | Written by Varsha Vats
A multifaceted approach that includes lifestyle modifications, medical support, and regular monitoring can lead to better health outcomes for those with PCOS.
-
www.ndtv.com
-
Metformin Cuts Risk Of Long COVID By 64%: Why The Diabetes Pill Is Not For Everyone
- Tuesday September 9, 2025
- Health | Written by Shreya Goswami
A UK study reveals that metformin, India's most prescribed diabetes medication, may slash the risk of Long COVID by 64%.
-
www.ndtv.com
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
How To Check Blood Sugar Correctly At Home: A Complete Guide
- Friday July 4, 2025
- Health | Varsha Vats
Regular monitoring allows you to see how your diet, exercise, and medications affect your blood sugar levels, helping you stay within your target range.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
The 25 Most Googled Health Questions In India This Year, And Their Answers
- Monday December 8, 2025
- Health | Written by Debosmita Ghosh
Top Health Googled Questions: Indians googled several queries related to issues like blood pressure, cholesterol, diabetes, kidney stones and more. Check here the most Googled health questions in India and their answers.
-
www.ndtv.com
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
- Tuesday December 2, 2025
- Health | NDTV
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
www.ndtv.com
-
US Adds New Grounds To Deny Visas: Obesity, Diabetes, Heart Disease
- Friday November 7, 2025
- World News | Edited by Anushree Jonko
Foreign nationals applying for a visa to live in the US might be rejected if they have health conditions such as diabetes or obesity, according to a government directive issued by the Trump administration on Thursday.
-
www.ndtv.com
-
IIT Madras Patents Affordable, Painless Glucose Monitor For Diabetics
- Thursday November 6, 2025
- India News | Press Trust of India
Researchers at the Indian Institute of Technology Madras have patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients, officials said on Wednesday.
-
www.ndtv.com
-
Obesity: Why New Medications Are Not Miracle Cures
- Friday November 7, 2025
- Health | The Conversation
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
www.ndtv.com
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
- Thursday October 30, 2025
- Health | Written by NDTV Health Desk
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
www.ndtv.com
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
- Wednesday October 8, 2025
- Health | Edited by NDTV News Desk
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
How PCOS-Linked Insulin Resistance Increases Type-2 Diabetes Risk
- Tuesday September 9, 2025
- Health | Written by Varsha Vats
A multifaceted approach that includes lifestyle modifications, medical support, and regular monitoring can lead to better health outcomes for those with PCOS.
-
www.ndtv.com
-
Metformin Cuts Risk Of Long COVID By 64%: Why The Diabetes Pill Is Not For Everyone
- Tuesday September 9, 2025
- Health | Written by Shreya Goswami
A UK study reveals that metformin, India's most prescribed diabetes medication, may slash the risk of Long COVID by 64%.
-
www.ndtv.com
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
How To Check Blood Sugar Correctly At Home: A Complete Guide
- Friday July 4, 2025
- Health | Varsha Vats
Regular monitoring allows you to see how your diet, exercise, and medications affect your blood sugar levels, helping you stay within your target range.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com